New developments in the virus therapy of cancer: a historical review

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Oncolysis, the use of viruses to treat cancer, has a history dating back to the 1920s.
• Natural viral infections can occasionally lead to remission in leukemias and lymphomas, but direct viral inoculation for tumors has limited success.
• Genetically engineered or tumor-adapted viruses show potential for improved therapeutic outcomes.

Purpose of the Study:

• To review the historical and current applications of viruses in cancer therapy (oncolysis).
• To explore the potential of modified viruses and virally modified tumor cell vaccines for inducing antitumor immunity.
• To highlight the need for further research and technological advancements for clinical implementation.

Main Methods:

• Historical review of oncolysis and viral therapy in cancer treatment.
• Discussion of engineered viral strains and virally modified tumor cell vaccines.
• Emphasis on the importance of laboratory monitoring of host immunological responses.

Main Results:

• Natural viral infections rarely achieve durable remissions in leukemias and lymphomas.
• Direct inoculation with live viruses has shown limited efficacy in inducing complete tumor remission.
• Virally modified tumor cell membrane vaccines show promise in stimulating host antitumor immunity.

Conclusions:

• Significant advancements in technology and further research are required to optimize viral oncolysis and virally modified vaccines for clinical practice.
• Understanding and monitoring host immunological reactions are essential for successful tumor rejection and avoiding ineffective interventions.
• The development of effective viral-based cancer therapies necessitates a comprehensive approach combining virology, immunology, and advanced technological applications.